Welcome to LookChem.com Sign In|Join Free

CAS

  • or

863329-64-0

Post Buying Request

863329-64-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • (2R,3R,4R,5R)-5-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-hydroxy-4-methyltetrahydrofuran-3-yl benzoate

    Cas No: 863329-64-0

  • No Data

  • No Data

  • No Data

  • Chemlyte Solutions
  • Contact Supplier

863329-64-0 Usage

General Description

Cytidine, N-benzoyl-2'-C-methyl-, 3',5'-dibenzoate (9CI) is a chemical compound with the molecular formula C30H23N3O6. It is a derivative of cytidine, an important component of RNA. The compound is composed of a cytidine molecule with both the 2'-C-methyl and 3',5'-hydroxyl groups protected by benzoyl groups. This derivative compound has been studied for its potential use in chemical and biological research, particularly in the modification of nucleic acids and development of nucleoside analogs. It may also have applications in the pharmaceutical industry for the development of new drugs targeting nucleic acid metabolism.

Check Digit Verification of cas no

The CAS Registry Mumber 863329-64-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,3,3,2 and 9 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 863329-64:
(8*8)+(7*6)+(6*3)+(5*3)+(4*2)+(3*9)+(2*6)+(1*4)=190
190 % 10 = 0
So 863329-64-0 is a valid CAS Registry Number.

863329-64-0Relevant articles and documents

High-yield synthesis method of sofosbuvir and sofosbuvir prepared with method

-

, (2016/11/07)

The invention relates to a high-yield synthesis method of sofosbuvir and sofosbuvir prepared with the method. The method comprises steps as follows: (a) cytidine and benzoic anhydride are dissolved in a first organic solvent for a reaction; TIDPSCl2 is ad

METHODS FOR TREATING HCV

-

, (2013/03/28)

This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 863329-64-0